[EU]. Commission Implementing Regulation (EU) 2024/2848 of 11 November 2024 amending Implementing Regulation (EU) No 540/2011 as regards the approval periods of the active substances fenpyrazamine and flumetralin.

On 11 November 2024, the European Union amending Implementing Regulation No 540/2011 as regards the extension of the approval periods of the active substances Fenpyrazamine and Flumetralin.

Active substances Expiration of approval Extension of Approval Expiration date
Fenpyrazamine 31/05/2026 15/01/2025
Flumetralin 11/05/2026 15/01/2025

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.

See attached file for details:  https://eur-lex.europa.eu/eli/reg_impl/2024/2848/oj


Share post:
Related news
Cookie Policy

We use cookies to improve website and your experience. You can change your preferences at any time. To learn more, check out our Cookie Policy.